Pathology Doctors in Dubuque, IA Accepting Medicare

8 Pathology doctors found. Showing 1 - 8

Michelle Kurt-mangold, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 250 Mercy Drive, Rm G211, Dubuque, IA 52004 Phone: 563-589-9827

Andrew D Vanderheyden, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 350 N Grandview Ave, Dubuque, IA 52001 Phone: 563-589-2431    Fax: 563-556-0986

Virginia Dawn Burdine, MD Pathology - Hematology Medicare: Not Enrolled in Medicare Practice Location: 250 Mercy Dr, Dubuque, IA 52001 Phone: 563-589-8619

Timothy G Timmerman, M.D. Pathology - Cytopathology Medicare: Medicare Enrolled Practice Location: 250 Mercy Dr, Dubuque, IA 52004 Phone: 563-589-9615

John A. Brennan, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 350 N Grandview Ave, Dubuque, IA 52001 Phone: 563-589-2431

Paul G. Ellerbeck, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 350 N Grandview Ave, Dubuque, IA 52001 Phone: 563-589-2431

Christopher J Leigh, M.D. Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 250 Mercy Dr, Dubuque, IA 52004 Phone: 563-589-9615

Daniel D Slagel, M.D. Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 250 Mercy Dr, Dubuque, IA 52004 Phone: 563-589-9615

News Archive

Recognizing the critical role of CRNAs in providing quality health care

In honor of National CRNA Week (Jan. 19-25, 2020), Reps. Jan Schakowsky (D-IL), Lucille Roybal-Allard (D-CA), and Sam Graves (R-MO) today introduced a bipartisan resolution on the House floor, "Recognizing the roles and the contributions of America's Certified Registered Nurse Anesthetists and their role in providing quality health care for the public."

Micromet commences blinatumomab phase 2 trial for r/r B-precursor acute lymphoblastic leukemia

Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.

Female childhood cancer survivors have a good chance of conceiving

A new study examines fertility issues in male and female childhood cancer survivors who had received chemotherapy. The study found that while most female survivors still have a good chance of conceiving, male survivors are significantly less likely to father children.

Federal agencies sued over medical Marijuana statements

The Oakland, Calif.-based advocacy group Americans for Safe Access on Wednesday filed suit in Oakland federal court against HHS and FDA over statements the organizations have made about medical marijuana, citing several studies that found the drug might benefit HIV-positive people, the Los Angeles Times reports.

Read more Medical News

› Verified 3 days ago